In This Article
To evaluate oral care contract manufacturers, first check whether the proposed product, market and order plan fit a controlled commercial production route. A sample can show a sensory direction. It cannot by itself confirm packaging fit, documentation scope or repeat-supply control.
Use this overview to qualify a supplier across toothpaste, mouthwash and breath spray, then move into the relevant category review. The aim is to decide who should receive a complete brief and sample request. For available categories, start with the oral care manufacturing program.
Define the launch market, channel, intended user, category, formula status, packaging and first-order units per SKU. State mandatory claims for review, expected document support and the decision owner. Separate launch quantities from annual forecasts.
Ask the supplier to identify unresolved assumptions before quoting. Compare quotations only when formula route, pack components, testing, documents and quantity are aligned.
A supplier should explain the formula, sensory, packaging and production questions specific to each format. Use the Category Fit Matrix before deciding which samples to request.
| Category | Formula and sensory review | Packaging review | Production fit before sampling |
|---|---|---|---|
| Mouthwash | Define ingredient direction, appearance, flavor, cooling and alcohol preference. Identify stability questions for the proposed system. | Bottle material, closure, seal, label and fill volume. | Confirm the intended liquid filling route, component availability and the checks needed for the selected formula and pack. |
| Toothpaste | Define fluoride/fluoride-free/nHAp direction, abrasive system, testing needs, texture, foam and aftertaste. | Tube material, diameter, shoulder, cap, fill weight, print method and carton. | Confirm paste handling and the proposed tube-filling and sealing route. Identify commercial pack evaluations still needed. |
| Breath spray | Define formula direction, flavor, cooling and aftertaste in the intended spray format. | Bottle, pump, actuator, cap, materials and leakage expectations. | Confirm filling and assembly fit and how spray output, pattern and pack compatibility will be evaluated. |
Ask which formulation and pack decisions must be resolved before the sample can represent the intended product. Continue with the mouthwash manufacturer evaluation guide for category-specific qualification.
Check whether the sensory target and abrasive direction can be carried into a defined commercial tube specification. Use the toothpaste manufacturer evaluation checklist for a deeper review.
Assess the formula and dispensing system together. Ask for a plan to review the selected bottle and pump before treating a sample as a commercial reference. For detailed checks, use the breath spray manufacturer evaluation guide.
Confirm whether the proposal uses an existing private-label base, controlled modifications, custom OEM development or a buyer-owned specification. Agree the scope of revisions, ownership and access to specifications, and the process for technical transfer where relevant.
Use the OEM vs private label vs contract manufacturing guide to align terms before comparing offers. A route is suitable when it meets the brief with an understood development and approval workload.
Review evidence before samples, while recognizing that final product records are created later in the project. At this stage, request the process, a blank template or an authorized redacted example. Do not request other customers’ confidential formulas, identities or production records.
| Evidence before samples | What to establish |
|---|---|
| Approved specification | How formula versions, finished-product requirements and buyer approvals are recorded. |
| Packaging check | How component drawings, incoming checks and formula-pack compatibility are reviewed. |
| Batch and production records | How materials, production stages, checks and batch traceability are recorded. |
| Finished-product release | Which agreed criteria govern release, who authorizes it and how deviations are handled. |
| Documentation scope | Which documents can be supplied where applicable, by whom, at what stage and at what cost. |
| Change control | How formula, material, component or artwork changes are evaluated and approved before use. |
Check that the proposed controls apply to your category and project scope. A certificate alone does not explain the commercial approval and release process. Agree a project-specific document list rather than requesting “all certificates.”
Name the local party responsible for classification, claims, labels and any registrations or notifications. Ask the manufacturer to confirm its manufacturing-side support and exclusions. Do not assume that an export experience claim includes responsibility for your market authorization.
For US projects, ORALABX reviews cosmetic-scope oral care only and does not undertake US OTC or anticavity drug manufacturing. See the US manufacturing scope. Review the Europe manufacturing context and Saudi and GCC program separately for those destinations. The US business boundary does not establish a fluoride ban in Europe or GCC markets. Product and claim requirements need destination-specific review.
Ask what sample approval actually covers and what remains to be confirmed. A controlled handover should identify the approved formula and specification, selected packaging, artwork, required evaluations and sign-off owners.
For repeat supply, confirm how the supplier retains the approved reference, reviews component availability and manages substitutions. Agree how deviations, complaints and proposed changes are communicated. Follow the OEM process to align these decisions with production milestones.
ORALABX’s standard commercial MOQ is 10,000 units/SKU for bottles, sprays and tubes. Single-dose sachets require 100,000/SKU. Final quantities depend on the approved formula, pack specification and component minimums. Evaluate each SKU separately.
For an existing formula route, initial samples usually take 5–7 working days after the formula scope is confirmed. First-order mass production usually takes 45–60 days after formula, packaging, artwork and deposit confirmation. Shipping is additional. Custom development, further evaluations and special packaging need a separate schedule.
A supplier’s stated lead time is meaningful only when the start conditions are clear. Identify buyer approvals and local review milestones that could hold the schedule.
Use the ten criteria below in the same order for every supplier. Record “confirmed,” “open” or “not suitable,” with the supporting evidence and next owner. Resolve mandatory failures before comparing overall preference or price.
| Criterion | Question for qualification | Evidence or decision to record |
|---|---|---|
| 1. Category fit | Can the supplier support the intended category and format? | Relevant process scope and category-specific review. |
| 2. Formula route | Does the development route fit the brief? | Base/custom/transfer route, revisions and specification ownership. |
| 3. Packaging | Can the proposed components work with the product and line? | Component specifications and an agreed evaluation plan. |
| 4. Quality evidence | Are approval, traceability and release controls clear? | Authorized templates or explanations and agreed release criteria. |
| 5. Documents | Is the requested support actually available? | Document list, applicability, timing, owner and cost. |
| 6. Market scope | Does the project fit the supplier’s service boundary? | Destination, claims questions, exclusions and local responsibility. |
| 7. Communication | Can both teams manage approvals consistently? | Named contacts, consolidated feedback and version control. |
| 8. MOQ | Does the first-order quantity fit each SKU? | Units/SKU and formula/component minimum assumptions. |
| 9. Timeline | Are lead times tied to explicit start conditions? | Sample and production milestones plus shipping allowance. |
| 10. Repeat supply | How will approved requirements remain controlled? | Change approval, deviation handling and reorder reference. |
Complete the brief first if the destination market, first-order units per SKU, formula direction, packaging or internal decision owner is undefined. Ask for clarification of the manufacturing route while those decisions are being resolved.
For example, three flavors requested without separate SKU quantities cannot yet support a meaningful MOQ comparison. An unspecified pump or tube also leaves the commercial sample plan incomplete. Assign owners and decision dates to those gaps before commissioning the next round.
Qualify commercial fit, category capability, formula route, packaging, evidence, documentation and destination-market scope. Use the ten-item scorecard to record open decisions before requesting samples.
No. Use it for initial supplier selection, then follow the existing mouthwash, toothpaste or breath spray evaluation guide for the chosen format.
Ask for process explanations, blank templates or authorized redacted examples. Agree how project-specific records will be available without requesting another customer’s confidential material.
No. Confirm the commercial specification, packaging, artwork, relevant evaluations and release requirements before production approval.
Plan against the MOQ per SKU and obtain confirmation for the actual formula and packaging. Do not assume several flavors or categories can be combined into one minimum.
Send the category, target market, formula direction, packaging, first-order units per SKU and decision owner through the ORALABX project contact page. A complete brief lets the team review fit and define a useful sampling route.
Share your product type, target market, estimated volume and launch timeline. We will review the project scope and recommend the appropriate development path.
Best suited to brands, importers and distributors planning scalable commercial production.